Table 1. Overview of volunteer characteristics infected with PfSPZ Challenge.
Volunteer ID | Gender | No. ofPfSPZ | Route of administration | Time* | Parasites/μl** |
---|---|---|---|---|---|
02.1 | m | 200 | iv | 13.94 | 54 |
08.1 | m | 800 | iv | 10.88 | 2.5 |
08.2 | f | 800 | iv | 11.29 | 6 |
08.3 | m | 800 | iv | 11.99 | 6 |
08.4 | f | 800 | iv | 12.26 | 8.5 |
08.5 | m | 800 | iv | 12.08 | 9 |
25.1 | f | 2,500 | id | 15.34 | 11 |
25.2 | m | 2,500 | id | 13.87 | 8 |
25.3 | m | 2,500 | id | 12.89 | 3.5 |
32.1 | m | 3,200 | iv | 10.50 | 6.5 |
32.2 | m | 3,200 | iv | 11.05 | 7.5 |
32.3 | m | 3,200 | iv | 11.52 | 5.5 |
32.4 | f | 3,200 | iv | 11.11 | 6.5 |
32.5 | m | 3,200 | iv | 10.99 | 7.5 |
32.6 | m | 3,200 | iv | 11.00 | 10 |
32.7 | m | 3,200 | iv | 10.45 | 7 |
32.8 | m | 3,200 | iv | 11.55 | 9.5 |
32.9 | f | 3,200 | iv | 12.48 | 9 |
* Days between volunteer infection and positive thick blood smear (day malaria)
** Parasite density at diagnosis determined by thick blood smear
f: female; id: intradermal; iv: intravenous; m: male